CKD in Hispanics: Baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC Studies
- PMID: 21705121
- PMCID: PMC3577064
- DOI: 10.1053/j.ajkd.2011.05.010
CKD in Hispanics: Baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC Studies
Abstract
Background: Little is known regarding chronic kidney disease (CKD) in Hispanics. We compared baseline characteristics of Hispanic participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC (H-CRIC) Studies with non-Hispanic CRIC participants.
Study design: Cross-sectional analysis.
Setting & participants: Participants were aged 21-74 years with CKD using age-based estimated glomerular filtration rate (eGFR) at enrollment into the CRIC/H-CRIC Studies. H-CRIC included Hispanics recruited at the University of Illinois in 2005-2008, whereas CRIC included Hispanics and non-Hispanics recruited at 7 clinical centers in 2003-2007.
Factor: Race/ethnicity.
Outcomes: Blood pressure, angiotensin-converting enzyme (ACE)-inhibitor/angiotensin receptor blocker (ARB) use, and CKD-associated complications.
Measurements: Demographic characteristics, laboratory data, blood pressure, and medications were assessed using standard techniques and protocols.
Results: Of H-CRIC/CRIC participants, 497 were Hispanic, 1,650 were non-Hispanic black, and 1,638 were non-Hispanic white. Low income and educational attainment were nearly twice as prevalent in Hispanics compared with non-Hispanics (P < 0.01). Hispanics had self-reported diabetes (67%) more frequently than non-Hispanic blacks (51%) and whites (40%; P < 0.01). Blood pressure >130/80 mm Hg was more common in Hispanics (62%) than blacks (57%) and whites (35%; P < 0.05), and abnormalities in hematologic, metabolic, and bone metabolism parameters were more prevalent in Hispanics (P < 0.05), even after stratifying by entry eGFR. Hispanics had the lowest use of ACE inhibitors/ARBs among the high-risk subgroups, including participants with diabetes, proteinuria, and blood pressure >130/80 mm Hg. Mean eGFR was lower in Hispanics (39.6 mL/min/1.73 m(2)) than in blacks (43.7 mL/min/1.73 m(2)) and whites (46.2 mL/min/1.73 m(2)), whereas median proteinuria was higher in Hispanics (protein excretion, 0.72 g/d) than in blacks (0.24 g/d) and whites (0.12 g/d; P < 0.01).
Limitations: Generalizability; observed associations limited by residual bias and confounding.
Conclusions: Hispanics with CKD in the CRIC/H-CRIC Studies are disproportionately burdened with lower socioeconomic status, more frequent diabetes mellitus, less ACE-inhibitor/ARB use, worse blood pressure control, and more severe CKD and associated complications than their non-Hispanic counterparts.
Published by Elsevier Inc.
References
-
- The Hispanic Population: Census 2000 Brief. U S Census Bureau [serial online] 2004
-
- USRDS 2009 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda: National Institute of Diabetes and Digestive and Kidney Diseases; 2009. US Renal Data System.
-
- Pugh JA, Stern MP, Haffner SM, Eifler CW, Zapata M. Excess incidence of treatment of end-stage renal disease in Mexican Americans. Am J Epidemiol. 1988;127:135–144. - PubMed
Publication types
MeSH terms
Grants and funding
- UL1 RR024989/RR/NCRR NIH HHS/United States
- R01 DK072231/DK/NIDDK NIH HHS/United States
- K24 DK002651/DK/NIDDK NIH HHS/United States
- U01 DK060963/DK/NIDDK NIH HHS/United States
- RR-05096/RR/NCRR NIH HHS/United States
- K24 DK062234/DK/NIDDK NIH HHS/United States
- R01 HL088577/HL/NHLBI NIH HHS/United States
- U01 DK060990/DK/NIDDK NIH HHS/United States
- M01 RR000042/RR/NCRR NIH HHS/United States
- M01 RR-000042/RR/NCRR NIH HHS/United States
- UL1 RR024986/RR/NCRR NIH HHS/United States
- UL1 RR024134/RR/NCRR NIH HHS/United States
- U01 DK061028/DK/NIDDK NIH HHS/United States
- UL1 RR-025005/RR/NCRR NIH HHS/United States
- UL1 RR-024989/RR/NCRR NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- U01 DK060984/DK/NIDDK NIH HHS/United States
- U01 DK061021/DK/NIDDK NIH HHS/United States
- U01 DK060980/DK/NIDDK NIH HHS/United States
- UL1 RR-024131/RR/NCRR NIH HHS/United States
- M01 RR-013987-06/RR/NCRR NIH HHS/United States
- 5U01DK060990/DK/NIDDK NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- R56 DK072231/DK/NIDDK NIH HHS/United States
- 5U01DK060902/DK/NIDDK NIH HHS/United States
- M01 RR013987/RR/NCRR NIH HHS/United States
- M01 RR005096/RR/NCRR NIH HHS/United States
- M01 RR016500/RR/NCRR NIH HHS/United States
- U01 DK060902/DK/NIDDK NIH HHS/United States
- M01 RR-16500/RR/NCRR NIH HHS/United States
- UL1 RR-024134/RR/NCRR NIH HHS/United States
- 5K24DK002651/DK/NIDDK NIH HHS/United States
- UL1 RR-024986/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous